Skip to main content

Table 3 Summary of the end-procedural angiography results

From: In vivo canine study of three different coatings applied to p64 flow-diverter stents: initial biocompatibility study

Animal number

Medication

Right CCA/ECA

Left CCA/ECA

Right SA

Left SA

1

None

p64 HPC-1 transient small thrombus

p64 uncoated, transient, small thrombus

p64 HPC-2, patent

p64 HPC-3, patent

2

ASA

p64 HPC-1, transient small thrombus

p64 uncoated, transient small thrombus

p64 HPC 2, patent

p64 HPC-3, patent

3

ASA

p64 HPC-2, small clot

p64 HPC-1, small clot

p64 HPC-3, patent

p64 uncoated, patent

4

ASA + clopidogrel

p64 HPC-2, patent

p64 HPC-1, patent

p64 HPC-, patent

p64 uncoated, patent

  1. ASA acetylsalicylic acid, CCA common carotid artery, ECA external carotid artery, SA subclavian artery